All Stories

  1. Blood-based Biomarkers of Alzheimer’s Disease: The Long and Winding Road

    Article • Current Pharmaceutical Design, May 2020, Bentham Science Publishers

    Dr Marcia R Cominetti, Patricia Manzine

  2. Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease

    Article • Expert Opinion on Investigational Drugs, December 2018, Taylor & Francis

    Dr Antonio Camins, Patricia Manzine, Professor Carme Auladell

  3. microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer’s Disease

    Article • Journal of Alzheimer s Disease, November 2017, IOS Press

    Patricia Manzine, Dr Marcia R Cominetti

  4. BACE1 levels are increased in plasma of Alzheimer's disease patients compared with matched cognitively healthy controls

    Article • Personalized Medicine, November 2016, Future Medicine

    Patricia Manzine, Dr Marcia R Cominetti